Shantha Biotech introduces DTPH combination vaccine
Shantha Biotechnics has announced the availability of a combination DTPH vaccine. Shantetra is the first indigenously developed and produced four-in-one vaccine.

Glenmark’s Oglemilast gets FDA approval for clinical trial
Glenmark Pharma-ceuticals SA (GPSA) announced that the group’s lead PDE-4 inhibitor GRC 3886 has received US Food and Drug Administration (USFDA) approval to proceed further in clinical testing within United States. The molecule has also been granted its International Non-proprietary Name (INN) “Oglemilast” by a World Health Organisation (WHO) body.